Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2019, Article ID 4170615, 8 pages
https://doi.org/10.1155/2019/4170615
Research Article

The Incremental Cost of Delivering PrEP as a Bridge to ART for HIV Serodiscordant Couples in Public HIV Care Clinics in Kenya

1Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya
2Department of Global Health, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA
3College of Health Sciences, Jomo Kenyatta University of Agriculture and Technology, P.O. Box 62000-00200, Nairobi, Kenya
4Department of Epidemiology, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA
5Department of Medicine, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA
6Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Correspondence should be addressed to Elizabeth M. Irungu; gro.akihtspip@ugnurie

Received 21 July 2018; Revised 3 January 2019; Accepted 31 March 2019; Published 2 May 2019

Academic Editor: David Katzenstein

Copyright © 2019 Elizabeth M. Irungu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Joint United Nations Programme on HIV/AIDS, UNAIDS Data 2018, Geneva, Switzerland, 2018.
  2. UNAIDS, Global AIDS Update, Geneva, Switzerland, 2016.
  3. K. L. Dunkle, R. Stephenson, E. Karita et al., “New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data,” The Lancet, vol. 371, no. 9631, pp. 2183–2191, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. K. L. Grabbe and R. Bunnell, “Reframing HIV prevention in sub-Saharan Africa using couple-centered approaches,” Journal of the American Medical Association, vol. 304, no. 3, pp. 346-347, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. National AIDS and STI Control Programme (NASCOP), Kenya AIDS Indicator Survey 2012: Final Report, NASCOP, Nairobi Kenya, 2012.
  6. D. Donnell, J. M. Baeten, J. Kiarie et al., “Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis,” The Lancet, vol. 375, no. 9731, pp. 2092–2098, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. S. Cohen, Y. Q. Chen, and M. McCauley, “Prevention of HIV-1 infection with early antiretroviral therapy,” The New England Journal of Medicine, vol. 365, no. 6, pp. 493–505, 2011. View at Publisher · View at Google Scholar
  8. I. Cremin, R. Alsallaq, M. Dybul, P. Piot, G. Garnett, and T. B. Hallett, “The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis,” AIDS, vol. 27, no. 3, pp. 447–458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. W. Eaton, L. F. Johnson, J. A. Salomon et al., “HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa,” Plos Medicine, vol. 9, no. 7, Article ID e1001245, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. R. M. Granich, C. F. Gilks, C. Dye, K. M. de Cock, and B. G. Williams, “Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model,” The Lancet, vol. 373, no. 9657, pp. 48–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. I. T. Katz and D. R. Bangsberg, “Cascade of refusal—what does it mean for the future of treatment as prevention in sub-saharan Africa?” Current HIV/AIDS Reports, vol. 13, no. 2, pp. 125–130, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Celum, A. Wald, J. R. Lingappa et al., “Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2,” The New England Journal of Medicine, vol. 362, no. 5, pp. 427–439, 2010. View at Google Scholar
  13. M. S. Cohen, Y. Q. Chen, M. McCauley et al., “Antiretroviral therapy for the prevention of HIV-1 transmission,” The New England Journal of Medicine, vol. 375, no. 9, pp. 830–839, 2016. View at Google Scholar
  14. J. M. Baeten, R. Heffron, L. Kidoguchi et al., “Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1–serodiscordant couples: a prospective implementation study in Kenya and Uganda,” Plos Medicine, vol. 13, no. 8, Article ID e1002099, 2016. View at Publisher · View at Google Scholar
  15. T. B. Hallett, J. M. Baeten, R. Heffron et al., “Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study,” Plos Medicine, vol. 8, no. 11, Article ID e1001123, 2011. View at Publisher · View at Google Scholar
  16. R. Ying, M. Sharma, R. Heffron et al., “Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda,” Journal of the International AIDS Society, vol. 18, no. 4 , Suppl 3, Article ID 20013, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. National AIDS and STI Control Programme (NASCOP), Guidelines on Use of Antiretroviral Drugs for Treating and Preventing HIV Infections in Kenya, 2016.
  18. World Health Organization, Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV, World Health Organization, Geneva, Switzerland, 2015.
  19. R. Heffron, K. Ngure, J. Odoyo et al., “Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa,” Gates Open Research, vol. 1, p. 3, 2017. View at Publisher · View at Google Scholar
  20. E. M. Kahle, J. P. Hughes, J. R. Lingappa et al., “An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention,” Journal of Acquired Immune Deficiency Syndromes, vol. 62, no. 3, pp. 339–347, 2013. View at Publisher · View at Google Scholar
  21. E. M. Irungu, R. Heffron, N. Mugo et al., “Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention,” BMC Infectious Diseases, vol. 16, no. 1, p. 571, 2016. View at Publisher · View at Google Scholar
  22. UNAIDS, Costing Guidelines for HIV Prevention Strategies, UNAIDS, Geneva, Switzerland, 2000.
  23. Central Bank of Kenya, Forex, 2017, https://www.centralbank.go.ke/forex/.
  24. Clinton Health Access Initiative, Antiretroviral (ARV) CHAI Reference List, 2015.
  25. U.S. Centers for Diseases Control and Kenya Ministry of Health, Report of a Cost Study of HIV Treatment Programs in Kenya, Nairobi, Kenya, 2013.
  26. Civil Servants Salaries, Allowances and Job Groups in Kenya, 2015, http://blog.calculator.co.ke/civil-servants-salaries-allowances-in-kenya/.
  27. E. A. Owiti, Cost Effectiveness and Survival Analysis of HIV and AIDS Treatment in Kenya, University of Nairobi, 2013.
  28. Nairobi City County Gazette Supplement No.7 (Acts No. 2), The Government Printer, Nairobi, Kenya, 2013.
  29. Public Procurement Oversight Authority (PPOA), Market Price Index, Nairobi, Kenya, 2013.
  30. Institute for Health Metrics and Evaluation (IHME), Health Service Provision in Kenya: Assessing Facility Capacity, Costs of Care, and Patient Perspectives, IHME, Seattle, WA, USA, 2014.
  31. B. Castelnuovo, J. Babigumira, M. Lamorde, A. Muwanga, A. Kambugu, and R. Colebunders, “Improvement of the patient flow in a large urban clinic with high HIV seroprevalence in Kampala, Uganda,” International Journal of STD & AIDS, vol. 20, no. 2, pp. 123-124, 2009. View at Publisher · View at Google Scholar · View at Scopus